@Redchip68 : your assessment is correct
@frenchfries57 :“every 10% reduction in proteinuria is an extra 5 years of life”. Utter rubbish
@vintage : your claim about relative safety is deceptive. Quote from the published traver duplex phase 3: “sparsentan and irbesartan had similar safety profiles, and the frequency of adverse events was similar in the two groups”.
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference, page-52
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.030(7.32%) |
Mkt cap ! $242.2M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 45.8¢ | 42.0¢ | $1.241M | 2.815M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21639 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 14976 | 2 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |